MedPath

The Effect of Sildenafil on Sleep-Disordered Breathing in Obese Patients With Sexual Dysfunction

Conditions
Sildenafil
Sleep Apnea
Sexual Dysfunction
Obesity
Registration Number
NCT00893191
Lead Sponsor
Assaf-Harofeh Medical Center
Brief Summary

Sildenafil has been shown to aggravate sleep-disordered breathing in patients with severe obstructive sleep apnea. The aim of the present study is to examine the frequency of sleep-disordered breathing in obese patients who are candidates for treatment with sildenafil for sexual dysfunction. In addition we wish to assess the effect of sildenafil on sleep-disordered breathing.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • Age - 40-65 years
  • BMI equal to or over 30
Exclusion Criteria
  • A known cardiorespiratory, liver or kidney disease
  • Treatment with nitrates or alfa blockers
  • Performed polysomnography in the past

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
apnea hypopnea index after sildenafil vs. placeboHours
Secondary Outcome Measures
NameTimeMethod
Sleep parameters (latency, efficiency etc) following sildenafil vs. placebohours

Trial Locations

Locations (1)

Asaf Harofeh Medical Center

🇮🇱

Zerifin, Israel

© Copyright 2025. All Rights Reserved by MedPath